1887

Abstract

Human immunodeficiency virus 1 (HIV-1) downregulates cell surface expression of HLA-A and HLA-B but not HLA-C or HLA-E to ultimately escape immune defences. Here, it is shown that cell surface expression of the non-classical HLA-G1 is also downregulated by HIV-1, by using co-transfection experiments and infection with cell-free HIV-1 of HLA-G1-expressing U87 glioma cells or macrophages in primary culture. Moreover, co-transfection experiments using proviruses deleted in either or or plasmids encoding HIV-1 Nef and Vpu mixed together with a HLA-G1-expressing construct demonstrated that HLA-G1 downregulation is Nef-independent and Vpu-dependent, contrasting with the Nef- and Vpu-dependent HLA-A2 downregulation. Together, these results show that the decrease of HLA-A2 and HLA-G1 caused by HIV-1 occurs through distinct mechanisms.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.79867-0
2004-07-01
2021-03-09
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/7/vir851945.html?itemId=/content/journal/jgv/10.1099/vir.0.79867-0&mimeType=html&fmt=ahah

References

  1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. 1986; Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284–291
    [Google Scholar]
  2. Besnard-Guérin C., Belaïdouni N., Lassot I., Segaral E., Jobart A., Marchal C., Benarous R. 2004; HIV-1 Vpu sequesters β -transducin repeat-containing protein ( β TrCP) in the cytoplasm and provokes the accumulation of β -catenin and other SCF β TrCP substrates. J Biol Chem 279:788–795 [CrossRef]
    [Google Scholar]
  3. Blagoveshchenskaya A. D., Thomas L., Feliciangeli S. F., Hung C. H., Thomas G. 2002; HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111:853–866 [CrossRef]
    [Google Scholar]
  4. Bour S., Schubert U., Strebel K. 1995; The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J Virol 69:1510–1520
    [Google Scholar]
  5. Bour S., Perrin C., Akari H., Strebel K. 2001; The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of IkappaB. J Biol Chem 276:15920–15928 [CrossRef]
    [Google Scholar]
  6. Buonocore L., Turi T. G., Crise B., Rose J. K. 1994; Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 204:482–486 [CrossRef]
    [Google Scholar]
  7. Cohen G. B., Gandhi R. T., Davis D. M., Mandelboim O., Chen B. K., Strominger J. L., Baltimore D. 1999; The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661–671 [CrossRef]
    [Google Scholar]
  8. Collins K. L., Baltimore D. 1999; HIV's evasion of the cellular immune response. Immunol Rev 168:65–74 [CrossRef]
    [Google Scholar]
  9. Corbeau P., Benkirane M., Weil R., David C., Emiliani S., Olive D., Mawas C., Serre A., Devaux C. 1993; Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. J Immunol 150:290–301
    [Google Scholar]
  10. Deng H., Unutmaz D., KewalRamani V. N., Littman D. R. 1997; Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296–300 [CrossRef]
    [Google Scholar]
  11. Fisher S., Genbacev O., Maidji E., Pereira L. 2000; Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 74:6808–6820 [CrossRef]
    [Google Scholar]
  12. Fournel F., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., Bensussan A., Le Bouteiller P. 2000; Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164:6100–6104 [CrossRef]
    [Google Scholar]
  13. Geraghty D. E., Koller B. H., Orr H. T. 1987; A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A 84:9145–9149 [CrossRef]
    [Google Scholar]
  14. Gromme M., Neefjes J. 2002; Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol 39:181–202 [CrossRef]
    [Google Scholar]
  15. Halary F., Amara A., Lortat-Jacob H. 7 other authors 2002; Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17:653–664 [CrossRef]
    [Google Scholar]
  16. Ishitani A., Geraghty D. E. 1992; Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 88:3947–3951
    [Google Scholar]
  17. Ishitani A., Sageshima N., Lee N., Dorofeeva N., Hatake K., Marquardt H., Geraghty D. E. 2003; Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 171:1376–1384 [CrossRef]
    [Google Scholar]
  18. Kerkau T., Bacik I., Bennink J. R., Yewdell J. W., Hunig T., Schimpl A., Schubert U. 1997; The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med 185:1295–1305 [CrossRef]
    [Google Scholar]
  19. Kikkert M., Hassink G., Barel M., Hirsch C., Van Der Wal F. J., Wiertz E. 2001; Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. Biochem J 358:369–377 [CrossRef]
    [Google Scholar]
  20. Klimkait T., Strebel K., Hoggan M. D., Martin M. A., Orenstein J. M. 1990; The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J Virol 64:621–629
    [Google Scholar]
  21. Le Bouteiller P., Blaschitz A. 1999; The functionality of HLA-G is emerging. Immunol Rev 167:233–244 [CrossRef]
    [Google Scholar]
  22. Lee N., Malacko A. R., Ishitani A., Chen M. C., Bajorath J., Marquardt H., Geraghty D. E. 1995; The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591–600 [CrossRef]
    [Google Scholar]
  23. Lefebvre S., Antoine M., Uzan S., McMaster M., Dausset J., Carosella E. D., Paul P. 2002; Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 196:266–274 [CrossRef]
    [Google Scholar]
  24. Lemonnier F. A., Le Bouteiller P., Olive D. 7 other authors 1984; Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody. J Immunol 132:1176–1182
    [Google Scholar]
  25. Lenburg M. E., Landau N. R. 1993; Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J Virol 67:7238–7245
    [Google Scholar]
  26. Lenfant F., Pizzato N., Liang S., Davrinche C., Le Bouteiller P., Horuzsko A. 2003; Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J Gen Virol 84:307–317 [CrossRef]
    [Google Scholar]
  27. Lila N., Rouas-Freiss N., Dausset J., Carpentier A., Carosella E. D. 2001; Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 98:12150–12155 [CrossRef]
    [Google Scholar]
  28. Lopez-Botet M., Llano M., Navarro F., Bellon T. 2000; NK cell recognition of non-classical HLA class I molecules. Semin Immunol 12:109–119 [CrossRef]
    [Google Scholar]
  29. Lozano J. M., Gonzalez R., Kindelan J. M., Rouas-Freiss N., Caballos R., Dausset J., Carosella E. D., Pena J. 2002; Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16:347–351 [CrossRef]
    [Google Scholar]
  30. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., Fauchet R. 2000; Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164:6426–6434 [CrossRef]
    [Google Scholar]
  31. Park B., Lee S., Kim E., Chang S., Jin M., Ahn K. 2001; The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. Immunity 15:213–224 [CrossRef]
    [Google Scholar]
  32. Perez-Bercoff D., David A., Sudry H., Barré-Sinoussi F., Pancino G. 2003; Fc γ receptor-mediated suppression of HIV replication in primary human macrophages. J Virol 77:4081–4094 [CrossRef]
    [Google Scholar]
  33. Schust D. J., Tortorella D., Ploegh H. L. 1999; HLA-G and HLA-C at the feto-maternal interface: lessons learned from pathogenic viruses. Semin Cancer Biol 9:37–46 [CrossRef]
    [Google Scholar]
  34. Schwartz O., Marechal V., Le Gall S., Lemonnier F., Heard J. M. 1996; Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338–342 [CrossRef]
    [Google Scholar]
  35. Solier C., Aguerre-Girr M., Lenfant F., Campan A., Berrebi A., Rebmann V., Grosse-Wilde H., Le Bouteiller P. 2002; Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 32:3576–3586 [CrossRef]
    [Google Scholar]
  36. Spencer J. V., Lockridge K. M., Barry P. A., Lin G., Tsang M., Penfold M. E., Schall T. J. 2002; Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76:1285–1292 [CrossRef]
    [Google Scholar]
  37. Tortorella D., Gewurz B. E., Furman M. H., Schust D. J., Ploegh H. L. 2000; Viral subversion of the immune system. Annu Rev Immunol 18:861–926 [CrossRef]
    [Google Scholar]
  38. Vincent M. J., Raja N. U., Jabbar M. A. 1993; Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J Virol 67:5538–5549
    [Google Scholar]
  39. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Bornemann A., Meyermann R., Weiss E. H., Melms A., Weller M. A. 2002; Functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 168:4772–4780 [CrossRef]
    [Google Scholar]
  40. Williams M., Roeth J. F., Kasper M. R., Fleis R. I., Przybycin C. G., Collins K. L. 2002; Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J Virol 76:12173–12184 [CrossRef]
    [Google Scholar]
  41. Yang Y., Chu W., Geraghty D. E., Hunt J. S. 1996; Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 156:4224–4231
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.79867-0
Loading
/content/journal/jgv/10.1099/vir.0.79867-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error